PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmelanoma
MeSH D008545 - melanoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D018326:Nevi and melanomas
0 Companies
0 Drugs
Success rate
D018358:Neuroendocrine tumors
$
Success rate
D012878:Skin neoplasms
$
Success rate
D008545: 
Melanoma
D008546:Experimental melanoma
0 Companies
0 Drugs
Success rate
D018327:Hutchinson's melanotic freckle
0 Companies
0 Drugs
Success rate
D018328:Amelanotic melanoma
$
Success rate
D000096142:Cutaneous malignant melanoma
0 Companies
0 Drugs
Success rate
D000098943:Uveal melanoma
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
74%
180/244
Phase 2
17%
50/286
Phase 3
55%
52/94
Approved: 33Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use